How should I evaluate and manage a subcutaneous mass?

Evaluation and Management of Subcutaneous Masses

Begin with plain radiographs for all subcutaneous masses, followed by ultrasound for superficial lesions, reserving MRI for deep masses, atypical features, or when malignancy cannot be excluded. 1

Initial Clinical Assessment

Focus on specific red flags that distinguish benign from potentially malignant lesions:

• Size ≥5 cm (though recent evidence suggests this threshold may be overly sensitive) 2
• Deep to fascia (versus superficial/subcutaneous)
• Rapid growth or sudden appearance
• Pain without trauma
• Fixed to underlying structures

Critical caveat: Size alone should not drive escalation of imaging—clinical context matters. A 2025 study found 99.8% of low-risk subcutaneous lesions <5cm were benign, and 50% of actual malignancies were <5cm 2. The combination of clinical features is more predictive than any single criterion.

Imaging Algorithm

Step 1: Plain Radiographs (Always First)

Obtain radiographs for every subcutaneous mass before any other imaging 1. This is fundamental despite being "often considered unrewarding."

Radiographs provide positive findings in 62% of cases:

• Calcification (27% of cases)—can identify phleboliths in hemangiomas, synovial chondromatosis
• Bone involvement (22%)—may reveal skeletal abnormality masquerading as soft tissue mass
• Intrinsic fat (11%)
• Foreign bodies
• Myositis ossificans pattern (peripheral mature ossification)

Limitations: Small, deep, non-mineralized masses or complex anatomical areas (flank, paraspinal, groin, deep hand/foot) 1

Step 2: Ultrasound for Superficial/Subcutaneous Lesions

Use ultrasound as the primary diagnostic tool for masses superficial to deep fascia 1

Ultrasound demonstrates excellent accuracy for superficial masses:

• Sensitivity: 94.1%, Specificity: 99.7% 1
• Highest accuracy for: Lipomas > vascular malformations > epidermoid cysts > nerve sheath tumors
• For lipomas specifically: 95.3% sensitivity, 100% specificity 2

Ultrasound characteristics of benign lipomas:

• Minimal/no acoustic shadowing
• Minimal/no vascularity
• Simple curved echogenic lines within encapsulated mass 1

Additional ultrasound utility:

• Differentiates solid from cystic
• Confirms ganglion cyst fluid content
• Identifies acute tenosynovitis
• Maps relationship to neurovascular structures

Mandatory escalation: If ultrasound or clinical features are atypical, proceed to MRI 1

Step 3: MRI for Deep Masses or Atypical Features

MRI is NOT appropriate as initial imaging but becomes the modality of choice for:

• Masses deep to fascia 1
• Atypical ultrasound findings
• Suspected sarcoma requiring surgical planning
• Complex anatomical locations where radiographs are limited

Do not use MRI in isolation—it cannot adequately identify mineralization 1

Imaging NOT Recommended Initially

• CT: Not for initial evaluation 1
• PET-CT: Not for initial evaluation 1

Tissue Diagnosis

Core Needle Biopsy (Preferred Method)

Obtain multiple core needle biopsies under image guidance for any mass concerning for malignancy 3

• Plan biopsy tract to allow excision with definitive surgery
• Risk of tract seeding is very small 3
• For large obvious masses, clinical guidance acceptable if clinician experienced

Fine needle aspiration is NOT recommended as primary diagnostic modality 3

Excisional Biopsy

Reserve for small (<2cm) indeterminate subcutaneous lesions where imaging cannot exclude benignity 3

Most prove benign; if sarcoma identified, perform subsequent wide excision of surgical bed.

Avoid "whoops surgery": Inadequate preoperative planning leading to marginal excision of sarcoma requires more extensive re-excision including hematoma areas 4

Specialized Staging (When Sarcoma Suspected)

Beyond standard chest CT, consider:

• Regional lymph node imaging (US or cross-sectional) for: synovial sarcoma, clear cell sarcoma, angiosarcoma, epithelioid sarcoma 3
• Abdominal/pelvic CT for myxoid liposarcoma (soft tissue metastases more common) 3
• Brain MRI for alveolar soft part sarcoma and clear cell sarcoma 3
• Chest X-ray may suffice for atypical lipomatous tumors without dedifferentiation (extremely low metastatic risk) 3

Management Principles

Benign Lesions

• Lipomas and epidermal cysts: Excise if painful or concern for malignancy 5
• Simple lipomas with characteristic ultrasound: Can manage conservatively or excise locally 2

High-Risk Features Requiring Specialist Referral

Refer to sarcoma MDT for:

• Deep to fascia
• Size ≥5cm with other concerning features
• Rapid growth
• Radiological high-risk features
• Atypical imaging regardless of size 3

Skin-Specific Sarcomas

Dermatofibrosarcoma protuberans (DFSP): Wide excision; consider Mohs surgery at critical anatomical sites 3

Atypical fibroxanthoma/pleomorphic dermal sarcoma: Core/punch biopsy first (not excisional biopsy) to plan for possible postoperative radiotherapy 3

Key Pitfalls to Avoid

1. Don't skip radiographs—they're positive in 62% of cases and may be diagnostic
2. Don't use size alone as indication for MRI—combine with clinical features
3. Don't perform excisional biopsy on lesions likely to be sarcoma—get core biopsy first
4. Don't use MRI as sole imaging—misses mineralization patterns
5. Don't delay specialist referral for deep masses or those with high-risk features—soft tissue sarcomas have high mortality 5